---
$id: https://graph.org.ai/products/commodity/51282129
$type: Product
source: UNSPSC
code: "51282129"
title: "Faropenem medoxomil"
class: "51282100"
classTitle: "Beta-lactams"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Faropenem medoxomil

**UNSPSC Code**: 51282129
**Class**: [Beta-lactams](Beta-lactams.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-lactam antibiotic C17H19NO8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5OK523O4FU, chemically known as (5-methyl-2-oxo-1,3-dioxoren-4-yl)methyl(5r,6s)-6-((r)-1-hydroxyethyl)-7-oxo-3-((r)-2-tetrahydrofuryl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate, but more generally known as faropenem medoxomil, which bears US NIH Compound Identifier 6918218. Most nations, for tariff and trade purposes, schedule faropenem medoxomil under HS 29419000 and SITC 54139. As of Q4 2014, FAROPENEM MEDOXOMIL remains US FDA's Preferred Term for this commodity. Faropenem medoxomil bears US NLM identifiers UMLS ID C1880735 and NCI Concept Code C65621. SMILES: CC1C(OC(=O)O1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4.

